title: Affordable Care Act Qualified Health Plan Enrollment for AIDS Drug Assistance Program Clients: Virginia's Experience and Best Practices.
abstract: With the implementation of the Affordable Care Act (ACA) in 2014, many safety net resources, including state AIDS Drug Assistance Programs (ADAPs), incorporated ACA Qualified Health Plans (QHPs) into their healthcare delivery model. This article highlights the benefits of the ACA for persons living with HIV. It also describes the range of strategies employed by state ADAPs to enroll patients in QHPs. The Virginia ADAP ACA implementation experience is described to illustrate one ADAP's shift to purchasing QHPs in addition to providing direct medications. Virginia ADAP is in a Medicaid nonexpansion state and funds the full costs of the QHP premiums, deductibles, and medication copayments. Virginia's experience is applicable to other Medicaid nonexpansion states and to state ADAPs in Medicaid expansion states, who are looking for options for their Medicaid ineligible clients. This article provides practical details of Virginia ADAP's ACA implementation as well as insights and best practices at both the state and clinic level.
authors.affiliation: 1 Division of Infectious Diseases and International Health, University of Virginia , Charlottesville, Virginia.
authors.forename: Kathleen A
authors.initials: KA
authors.lastname: McManus
authors.affiliation: 2 University of Virginia Ryan White HIV Clinic , Charlottesville, Virginia.
authors.forename: Robert C
authors.initials: RC
authors.lastname: Rodney
authors.affiliation: 3 Virginia Department of Health , Richmond, Virginia.
authors.forename: Anne
authors.initials: A
authors.lastname: Rhodes
authors.affiliation: 3 Virginia Department of Health , Richmond, Virginia.
authors.forename: Steven
authors.initials: S
authors.lastname: Bailey
authors.affiliation: 1 Division of Infectious Diseases and International Health, University of Virginia , Charlottesville, Virginia.
authors.forename: Rebecca
authors.initials: R
authors.lastname: Dillingham
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D006291:Health Policy; D006801:Humans; D058991:Patient Protection and Affordable Care Act; D017410:Practice Guidelines as Topic; D014768:Virginia
chemical_list: D019380:Anti-HIV Agents